Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain
Mechanisms and Utility of Multisensory Body- Representation in SCI and SCI-Related Neuropathic Pain
2 other identifiers
interventional
30
1 country
1
Brief Summary
The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2023
CompletedFirst Posted
Study publicly available on registry
August 24, 2023
CompletedStudy Start
First participant enrolled
October 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 20, 2026
November 21, 2025
November 1, 2025
3 years
August 18, 2023
November 19, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change in neuropathic pain severity assessed by Neuropathic Pain Symptom Inventory (NPSI)
The NPSI is a self-reported, validated questionnaire that includes 10 items (on different pain sensations, e.g., burning, squeezing, electric-shock, etc.) used to evaluate the properties of neuropathic pain. Each item is scored on an 11-point NRS (0 meaning no symptom and 10 meaning worst symptom), with higher scores indicating more severe neuropathic pain symptoms.
Baseline, up to 4 weeks
Change in neuropathic pain interference assessed by pain interference questionnaire.
The questionnaire consists in a numerical rating of pain interference ranging from 0= No Interference to 10=Extreme interference with activities, mood and sleep
Baseline, up to 4 weeks
Changes associated with sensory function/dysfunction assessed by quantitative sensory testing
The sensory test assesses thermal thresholds and includes: cool detection threshold (CDT), warm detection threshold (WDT), cold pain threshold (CPT), hot pain threshold (HPT), all performed using the method of limits: 0 to 50 Celsius (ºC) all values will be reported in Celsius.
Baseline, up to 4 weeks
Secondary Outcomes (3)
Change in manageable pain assessed by days of manageable pain questionnaire.
Baseline, up to 4 weeks
Changes of psychosocial assessed by Multidimensional Pain Inventory (pain severity subscale)
Baseline, up to 4 weeks
Change in Global impression of changes by PGIC questionnaire
Baseline, up to 4 weeks
Study Arms (1)
SCI with pain
EXPERIMENTALParticipants will undergo 2-4 weeks of combined intervention including transcranial direct current stimulation (tDCS) and bodily illusions (10 sessions total).
Interventions
Participants will be required to perform (in person) 10 interventions over a time frame of 2-4 weeks. They can perform this everyday or for a minimum of 2-3 times per week over 4 weeks. Two types of illusions will be used 15 min each, the rubber hand illusion and the walking illusion to target upper and lower limbs. These procedures will impact the body representation of the participants resulting in bodily illusions.
Eligibility Criteria
You may qualify if:
- SCI with Pain:
- Men or women
- fluent in English
- years of age who have: (3a) Complete and incomplete SCI, level of injury (above L1); (3b) Persistent neuropathic pain started after the injury for a minimum of three months prior to entering the study that is at least moderate in severity, defined as ≥ 4 on a Numeric Rating Scale (NRS) ranging 0 to 10.
You may not qualify if:
- Participants will be excluded if they have:
- Major psychiatric disease/disorder (self-reported);
- a significant neurological trauma (self-reported) other than SCI;
- a recent (one-year) history of alcohol or drug abuse assessed by the Drug Abuse Screening Test (DAST-10)
- history of visual and hearing loss not corrected
- history of epilepsy or seizures
- any metal implants in the head, or implanted devices such as cochlea implants or cardiac pacemakers.
- We will not include any special population like:
- Adults unable to consent Individuals who are not yet adults (infants, children, teenagers) Pregnant women Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Widerstrom-Noga, PhD
University of Miami
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 18, 2023
First Posted
August 24, 2023
Study Start
October 17, 2023
Primary Completion (Estimated)
October 20, 2026
Study Completion (Estimated)
October 20, 2026
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share